Kailera IPO interview: CEO Renaud talks biotech market, China and obesity pipeline
On Friday, Kailera Therapeutics raised a record-setting $625 million through an IPO on the Nasdaq. Founded with backing from Bain Capital Life Sciences, and a pipeline of obesity assets from China's Hengrui ...
Original Source
Read the full article at Endpoints →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.